期刊文献+

P-选择素在基底动脉尖综合征患者血清中的表达及尤瑞克林对其影响 被引量:1

The levels of serum P-selectin and the effect of urinary kallidinogenase on P-selectin in the patients with top of basilar artery syndrome
下载PDF
导出
摘要 目的观察基底动脉尖综合征患者血清P-选择素的动态变化及尤瑞克林对P-选择素表达的影响。方法将22例急性基底动脉尖综合征(TOBS)患者随机分为尤瑞克林治疗组和常规治疗组各11例,两组均给予常规抗血小板聚集、抗自由基、活血化瘀治疗,治疗组加用尤瑞克林治疗;测定患者治疗前、治疗后7d和21d血清P-选择素水平,并测定21例正常对照者血清P-选择素水平。结果与正常对照组比较,TOBS患者治疗前血清P-选择素水平显著升高(P<0.01);与治疗前相比,常规治疗组在治疗后7d下降无统计学意义(P>0.05),治疗后21d差异具有统计学意义(P<0.05);尤瑞克林治疗组在治疗后7d P-选择素水平下降显著(P<0.05),治疗后21d下降更加明显(P<0.01)。两组之间相比,治疗前血清P-选择素水平无显著性差异,治疗后尤瑞克林治疗组下降明显,治疗后7d(P<0.05),治疗后21d(P<0.01)。血清P-选择素水平与NIHSS评分呈正相关。结论血清P-选择素在TOBS患者中发病后升高,治疗后逐渐出现下降,尤瑞克林可降低血清P-选择素水平。 Objective To observe the changes of serum P-seleetin and the effect of urinary kallidinogenase on P-selectin in the patients with the top of basilar artery syndrome(TOBS). Methods 22 patients with TOBS were randomly di- vided into urinary kallidinogenase treatment group ( 11 patients) and conventional therapy group ( 11 patients). The level of P-seleetin was measured at prior treatment,7d after treatment and 21d after treatment. At the same time,the level of P-se- lectin was measured in 21h eahh adults in normal control group. Results The levels of serum P-seleetin in patients with TOBS were higher than those in the normal control group( P 〈0.01 ). The levels of serum P-selectin in TOBS were descend after treatment compared with prior treatment. In conventional therapy group, the descend had no statistical significance( P 〉 0.05 )on 7d after treatment, but had statistical significance (P 〈 0.05 )on 21 d after treatment. In urinary kallidinogenase treatment group, the descend had statistical significance on 7d of post-treatment ( P 〈 0.05 ) and 21 d of post-treatment ( P 〈 0.01 ). There was no statistical significance( P 〉 0.05 ) in the levels of P-seleetin between two treatment groups before treat- ment. But the levels of serum P-selectin in the urinary kallidinogenase treatment group were lower than those in convention- al therapy group on 7d after treatment(P 〈 0.05 ) and 21d after treatment ( P 〈 0.01 ). The level of serum P-selectin was positively correlated with NIHSS(P 〈 0.01 ). Conclusions The levels of serum P-selectin in patients with TOBS increases and then decreases after treatmeat. Urinary kallidinogenase can decrease the level of serum P-selectin in TOBS.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2012年第7期636-638,共3页 Journal of Apoplexy and Nervous Diseases
关键词 基底动脉尖综合征 P-选择素 尤瑞克林 Top of basilar artery syndrome P-selectin Urinary kallidinogenase
  • 相关文献

参考文献12

  • 1张海鸥,吴军,陈准菁,王春安.基底动脉尖综合征的临床及影像学研究[J].中风与神经疾病杂志,2004,21(1):56-56. 被引量:9
  • 2楼之茵,胡学强.基底动脉尖综合征研究进展[J].解剖学研究,2005,27(3):199-200. 被引量:23
  • 3朱祖福,韩伯军,王庆广,陆强彬.依达拉奉联合东菱迪芙治疗基底动脉尖综合征的临床观察[J].中风与神经疾病杂志,2011,28(1):58-59. 被引量:2
  • 4Wang X,Xu L,Wang H, et al. Inhibition of factor Xa reduces ische- mic brain damage after thromboembolic stroke in rats [ J ]. Stroke, 2003,34 (2) :468 - 474.
  • 5Turgut B, Turgut N, Celik Y, et al. Differences in platelet-leukocyte aggregates among subtypes of acute cerebral ischemia [ J ]. J Neurol Sei,2011,305(1 -2) :126 - 130.
  • 6Yilmaz G, Granger DN. Leukocyte recruitment and isehemic brain in- jury[ J]. Neuromolecular Med ,2010,12 (2) : 193 - 204.
  • 7Zhang R,Chopp M,Zhang Z,et al. The expression of P-and E-selec- tins in three models of middle cerebral artery occlusion [ J ]. Brain Res, 1998,785:207 - 214.
  • 8Leeb-Lundberg LM, Marceau F, Mailer-Ested W, et al. International union of pharmacology XLV, classification of the kinin receptor fami- ly:from molecular mechanisms to path ophysiological consequences [ J]. Pharmacol Rev,2005,57 ( 1 ) :72 - 77.
  • 9Spinetti G, Fortunato O, Cordella D, et al. Tissue kallikrein is essen- tial for invasive capacity of circulating proangiogenic cells [ J ]. Circ Res ,2011,108 (3) :284 - 293.
  • 10Caplan LR. Worsening in ischemic stroke patients:is it time for a new strategy [ J ]. Stroke,2002,33 : 1443 - 1445.

二级参考文献26

  • 1楼之茵,胡学强.基底动脉尖综合征研究进展[J].解剖学研究,2005,27(3):199-200. 被引量:23
  • 2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15755
  • 3Mehler MF. The rostral basilar artery syndrome: diagnosis, etiology, prognosis [ J 1. Neurology, 1989,39 ( 1 ) :9 - 16.
  • 4Mehler MF. Reversible rostral basilar artery syndrome[ J]. Arch Intern Med, 1998,148 ( 1 ) : 166 - 169.
  • 5Sato M,Tanaka S, Kohama A. "'Top of basilar" syndrome : clinicoradiological evaluation[J]. Neuroradiology,1987,29( 1 ) :354 -359.
  • 6Satoh K, IkedaY, Shioda S, et al. Edaravone scavenges nitric oxide [J]. Redox Rep,2002,7(4):219 -222.
  • 7Zhang N, Komine-Kobayashi M,Tanaka R, et al. Edaravone Reduces Early Accumulation of Oxidative Products and Sequential Inflammatory Responses After Transient Focal Ischemia in Mice Brain [ J ]. Stroke,2005,36 ( 10 ) :2220 - 2225.
  • 8Caplan LR. Top of the basilar syndrome. Neurology,1980,30: 72.
  • 9Sato M,Tanaka S, kohama A. Top of the basilar syndrome: clinico-radiological basilar evaluation.Neuroradiology, 1987,29: 354~359.
  • 10Carod Artal FJ, Vargas AP, Melo M, et al. Top of the basilar syndrome and Chagasdisease. Rev Neurol, 2002,351: 337~344.

共引文献31

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部